Anatara Total Current Assets vs Short Term Debt Analysis

ANR Stock

0.06 0 1.72%

Anatara Lifesciences financial indicator trend analysis is way more than just evaluating Anatara Lifesciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anatara Lifesciences is a good investment. Please check the relationship between Anatara Lifesciences Total Current Assets and its Short Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anatara Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Current Assets vs Short Term Debt

Total Current Assets vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anatara Lifesciences Total Current Assets account and Short Term Debt. At this time, the significance of the direction appears to have strong relationship.

The correlation between Anatara Lifesciences' Total Current Assets and Short Term Debt is 0.71. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Anatara Lifesciences, assuming nothing else is changed. The correlation between historical values of Anatara Lifesciences' Total Current Assets and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of Anatara Lifesciences are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Total Current Assets i.e., Anatara Lifesciences' Total Current Assets and Short Term Debt go up and down completely randomly.

Correlation Coefficient

0.71

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Short Term Debt

Most indicators from Anatara Lifesciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anatara Lifesciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anatara Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to gain to about 1.6 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 1.8 M in 2024.

	2021	2022	2023	2024 (projected)
Cost Of Revenue	24.7K	24.8K	748.9K	786.4K
Research Development	747.2K	1.6M	748.9K	781.0K

Cost Of Revenue Research Development

Anatara Lifesciences fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Cash	Net Receivables	Total Liab	Common Stock	Other Current Assets	Short Long Term Debt Total	Other Current Liab	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Current Assets	Short Term Debt	Net Tangible Assets	Common Stock Total Equity	Inventory	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Short Term Investments
Total Assets		0.33	0.8	0.23	0.36	0.33	0.25	-0.52	0.31	1.0	0.66	-0.81	0.25	0.43	0.99	-0.16	0.26	1.0	0.7	0.92	0.29	-0.13	0.15	0.18	-0.18	0.52
Total Current Liabilities	0.33		0.06	0.54	0.86	0.68	-0.1	-0.56	0.79	0.3	0.51	-0.08	-0.52	0.21	0.25	0.37	-0.26	0.33	-0.04	0.33	0.73	-0.32	0.03	0.08	-0.08	-0.09
Cash	0.8	0.06		0.2	-0.03	0.23	0.47	-0.43	0.04	0.82	0.55	-1.0	0.25	0.41	0.82	-0.17	0.04	0.8	0.57	0.62	0.14	-0.26	0.18	0.16	-0.17	0.19
Net Receivables	0.23	0.54	0.2		0.4	0.74	-0.27	-0.57	0.69	0.22	0.49	-0.22	-0.61	-0.06	0.13	0.49	-0.26	0.23	-0.26	0.28	0.77	-0.89	0.13	0.16	-0.15	-0.51
Total Liab	0.36	0.86	-0.03	0.4		0.49	0.02	-0.42	0.76	0.31	0.43	0.01	-0.33	0.08	0.25	0.21	-0.08	0.35	-0.17	0.34	0.55	-0.05	0.18	0.25	-0.25	0.12
Common Stock	0.33	0.68	0.23	0.74	0.49		-0.14	-0.89	0.6	0.32	0.79	-0.26	-0.81	0.52	0.25	0.71	-0.43	0.33	-0.02	0.29	0.94	-0.65	0.09	0.11	-0.1	-0.46
Other Current Assets	0.25	-0.1	0.47	-0.27	0.02	-0.14		-0.16	-0.11	0.25	0.25	-0.47	0.29	0.28	0.28	-0.25	0.19	0.25	0.27	-0.13	-0.33	0.32	0.02	0.02	-0.02	0.23
Short Long Term Debt Total	-0.52	-0.56	-0.43	-0.57	-0.42	-0.89	-0.16		-0.51	-0.51	-0.97	0.46	0.59	-0.6	-0.46	-0.54	0.29	-0.51	-0.25	-0.37	-0.71	0.51	-0.07	-0.09	0.08	0.29
Other Current Liab	0.31	0.79	0.04	0.69	0.76	0.6	-0.11	-0.51		0.27	0.47	-0.06	-0.4	-0.16	0.21	0.15	-0.21	0.31	-0.17	0.33	0.63	-0.42	0.08	0.14	-0.14	-0.13
Total Stockholder Equity	1.0	0.3	0.82	0.22	0.31	0.32	0.25	-0.51	0.27		0.66	-0.82	0.26	0.44	0.99	-0.16	0.27	1.0	0.73	0.92	0.27	-0.13	0.14	0.17	-0.17	0.51
Current Deferred Revenue	0.66	0.51	0.55	0.49	0.43	0.79	0.25	-0.97	0.47	0.66		-0.58	-0.43	0.6	0.62	0.43	-0.17	0.66	0.38	0.49	0.6	-0.41	0.07	0.09	-0.09	-0.12
Net Debt	-0.81	-0.08	-1.0	-0.22	0.01	-0.26	-0.47	0.46	-0.06	-0.82	-0.58		-0.21	-0.43	-0.83	0.13	-0.03	-0.81	-0.57	-0.62	-0.17	0.28	-0.17	-0.15	0.16	-0.18
Retained Earnings	0.25	-0.52	0.25	-0.61	-0.33	-0.81	0.29	0.59	-0.4	0.26	-0.43	-0.21		-0.28	0.33	-0.9	0.57	0.25	0.45	0.25	-0.79	0.6	0.05	0.05	-0.05	0.78
Accounts Payable	0.43	0.21	0.41	-0.06	0.08	0.52	0.28	-0.6	-0.16	0.44	0.6	-0.43	-0.28		0.46	0.41	-0.15	0.43	0.53	0.26	0.39	0.01	0.03	0.02	-0.02	0.06
Cash And Short Term Investments	0.99	0.25	0.82	0.13	0.25	0.25	0.28	-0.46	0.21	0.99	0.62	-0.83	0.33	0.46		-0.22	0.29	0.99	0.78	0.91	0.2	-0.06	0.12	0.15	-0.15	0.57
Common Stock Shares Outstanding	-0.16	0.37	-0.17	0.49	0.21	0.71	-0.25	-0.54	0.15	-0.16	0.43	0.13	-0.9	0.41	-0.22		-0.32	-0.16	-0.3	-0.17	0.7	-0.5	-0.28	-0.28	0.29	-0.65
Other Stockholder Equity	0.26	-0.26	0.04	-0.26	-0.08	-0.43	0.19	0.29	-0.21	0.27	-0.17	-0.03	0.57	-0.15	0.29	-0.32		0.27	0.4	0.26	-0.39	0.34	-0.34	-0.3	0.3	0.69
Total Current Assets	1.0	0.33	0.8	0.23	0.35	0.33	0.25	-0.51	0.31	1.0	0.66	-0.81	0.25	0.43	0.99	-0.16	0.27		0.71	0.92	0.29	-0.12	0.15	0.18	-0.18	0.52
Short Term Debt	0.7	-0.04	0.57	-0.26	-0.17	-0.02	0.27	-0.25	-0.17	0.73	0.38	-0.57	0.45	0.53	0.78	-0.3	0.4	0.71		0.62	-0.12	0.18	-0.13	-0.12	0.12	0.64
Net Tangible Assets	0.92	0.33	0.62	0.28	0.34	0.29	-0.13	-0.37	0.33	0.92	0.49	-0.62	0.25	0.26	0.91	-0.17	0.26	0.92	0.62		0.34	-0.18	0.17	0.2	-0.2	0.52
Common Stock Total Equity	0.29	0.73	0.14	0.77	0.55	0.94	-0.33	-0.71	0.63	0.27	0.6	-0.17	-0.79	0.39	0.2	0.7	-0.39	0.29	-0.12	0.34		-0.69	0.04	0.07	-0.07	-0.42
Inventory	-0.13	-0.32	-0.26	-0.89	-0.05	-0.65	0.32	0.51	-0.42	-0.13	-0.41	0.28	0.6	0.01	-0.06	-0.5	0.34	-0.12	0.18	-0.18	-0.69		-0.1	-0.1	0.1	0.64
Property Plant And Equipment Net	0.15	0.03	0.18	0.13	0.18	0.09	0.02	-0.07	0.08	0.14	0.07	-0.17	0.05	0.03	0.12	-0.28	-0.34	0.15	-0.13	0.17	0.04	-0.1		0.99	-0.99	-0.04
Non Current Assets Total	0.18	0.08	0.16	0.16	0.25	0.11	0.02	-0.09	0.14	0.17	0.09	-0.15	0.05	0.02	0.15	-0.28	-0.3	0.18	-0.12	0.2	0.07	-0.1	0.99		-1.0	0.0
Non Currrent Assets Other	-0.18	-0.08	-0.17	-0.15	-0.25	-0.1	-0.02	0.08	-0.14	-0.17	-0.09	0.16	-0.05	-0.02	-0.15	0.29	0.3	-0.18	0.12	-0.2	-0.07	0.1	-0.99	-1.0		-0.01
Short Term Investments	0.52	-0.09	0.19	-0.51	0.12	-0.46	0.23	0.29	-0.13	0.51	-0.12	-0.18	0.78	0.06	0.57	-0.65	0.69	0.52	0.64	0.52	-0.42	0.64	-0.04	0.0	-0.01

Click cells to compare fundamentals

Anatara Lifesciences Account Relationship Matchups

Anatara Lifesciences fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.3M	4.3M	1.8M	1.4M	1.7M	1.6M
Total Current Liabilities	464.0K	402.6K	358.1K	494.2K	304.2K	369.0K
Cash	2.7M	3.4M	1.1M	351.2K	982.1K	933.0K
Net Receivables	630.3K	772.6K	508.5K	1.0M	671.1K	518.6K
Total Liab	487.0K	496.7K	403.4K	494.8K	306.8K	433.2K
Common Stock	17.0M	19.8M	19.9M	21.4M	23.2M	14.6M
Other Current Assets	23.7K	37.1K	22.0K	10.9K	17.4K	16.6K
Other Current Liab	430.2K	192.9K	184.8K	415.3K	56.1K	53.3K
Total Stockholder Equity	2.9M	3.8M	1.4M	924.5K	1.4M	1.3M
Net Debt	(2.7M)	(3.4M)	(1.1M)	(351.2K)	(982.1K)	(1.0M)
Retained Earnings	(14.7M)	(16.6M)	(19.0M)	(20.8M)	(22.1M)	(21.0M)
Accounts Payable	33.9K	195.6K	152.6K	78.8K	248.0K	149.2K
Cash And Short Term Investments	2.7M	3.4M	1.2M	401.2K	982.1K	933.0K
Common Stock Shares Outstanding	54.6M	69.0M	78.2M	104.3M	150.0M	157.5M
Liabilities And Stockholders Equity	3.3M	4.3M	1.8M	1.4M	1.7M	1.6M
Other Stockholder Equity	(2.3M)	(3.2M)	(924.8K)	(576.8K)	(519.2K)	(545.1K)
Total Current Assets	3.3M	4.2M	1.7M	1.4M	1.7M	1.6M
Net Tangible Assets	2.9M	3.8M	1.4M	924.5K	832.1K	790.5K
Property Plant And Equipment Net	7.2K	85.0K	66.9K	3.3K	794.0	754.3
Non Current Assets Total	7.2K	85.0K	66.9K	3.3K	794.0	754.3
Non Currrent Assets Other	(27.2K)	(7.2K)	(85.0K)	(66.9K)	(3.3K)	0.0
Short Term Investments	6.2M	4.1M	0.0	50K	50.1K	47.6K
Property Plant And Equipment Gross	7.2K	85.9K	87.8K	3.3K	794.0	754.3
Accumulated Other Comprehensive Income	553.3K	678.5K	439.5K	347.7K	278.0K	442.9K
Property Plant Equipment	7.2K	85.0K	66.9K	3.3K	3.7K	3.6K
Non Current Liabilities Total	22.9K	94.1K	45.2K	665.0	2.7K	2.6K
Net Invested Capital	2.9M	3.8M	1.4M	924.5K	1.4M	1.3M
Net Working Capital	2.9M	3.8M	1.3M	921.9K	1.4M	1.3M
Other Liab	22.9K	28.3K	81.0	665.0	598.5	568.57
Capital Stock	17.0M	19.8M	19.9M	21.4M	23.2M	21.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Anatara Stock Analysis

When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC